Name | 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one |
---|---|
Synonyms |
1-Butanone, 1- (4-fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]-
Butyrophenone, 4'-fluoro-4-[4- (o-methoxyphenyl)-1-piperazinyl]- Anti-Pica 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)-piperazine-1-yl]butan-1-one Haloanisone N1-(2-Methoxy-phenyl)-N4-<3-(4-fluor-benzoyl)-propyl>-piperazin 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]- 1-(4-fluoro-phenyl)-4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butan-1-one MD 2028 4'-fluoro-4-[4-(o-methoxyphenyl)-1-piperazinyl]butyrophenone Fluanisonum [INN-Latin] 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]-1-butanone Sedalande Fluanison Metorin 4-[4-(o-Methoxyphenyl)-1-piperazinyl]-p-fluorobutyrophenone 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one fluanisone Haloanison |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 511.8±50.0 °C at 760 mmHg |
Melting Point | 67.5-68.5° |
Molecular Formula | C21H25FN2O2 |
Molecular Weight | 356.434 |
Flash Point | 263.3±30.1 °C |
Exact Mass | 356.190002 |
PSA | 32.78000 |
LogP | 3.43 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.558 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
HS Code | 2933599090 |
---|
~92% 1480-19-9 |
Literature: Narsaiah, A. Venkat; Nagaiah; Devi, B. Karuna Journal of Heterocyclic Chemistry, 2012 , vol. 49, # 4 p. 829 - 832 |
~% 1480-19-9 |
Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
~% 1480-19-9 |
Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
~% 1480-19-9 |
Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
~% 1480-19-9 |
Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
~% 1480-19-9 |
Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
Precursor 5 | |
---|---|
DownStream 0 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |